- Application of Apoptogenic Pretreatment to Enhance Anti-tumor Immunity of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF)-secreting CT26 Tumor Cells
-
Jun DY, Jaffee EM, Kim YH
- KMID: 2150605
- Immune Netw.
- 2005 Jun;5(2):110-116.
- doi: 10.4110/in.2005.5.2.110
BACKGROUND: As an attempt to develop a strategy to improve the protective immune response to GM-CSF-secreting CT26 (GM-CSF/CT26) tumor vaccine, we have investigated whether the apoptogenic treatment of GM-CSF/CT26 prior... -
- CITED
-
- Close
- SHARE
-
- Close
- Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
-
Mohammed A, Dashwood RH, Dickinson S, Disis ML, Jaffee EM, Johnson 6 BD, Khleif SN, Pollak MN, Schlom J, Shoemaker RH, Stanton SE, Wondrak GT, You M, Zhu H, Miller MS
- KMID: 2524126
- J Cancer Prev.
- 2021 Dec;26(4):309-317.
- doi: 10.15430/JCP.2021.26.4.309
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on... -
- CITED
-
- Close
- SHARE
-
- Close
